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Abstract
Background: The prevalence and impact of musculoskeletal conditions are predicted to rapidly escalate in the
coming decades. Effective strategies are required to minimise ‘evidence-practice’, ‘burden-policy’ and ‘burden-service’
gaps and optimise health system responsiveness for sustainable, best-practice healthcare. One mechanism by which
evidence can be translated into practice and policy is through Models of Care (MoCs), which provide a blueprint for
health services planning and delivery. While evidence supports the effectiveness of musculoskeletal MoCs for
improving health outcomes and system efficiencies, no standardised national approach to evaluation in terms of their
‘readiness’ for implementation and ‘success’ after implementation, is yet available. Further, the value assigned to MoCs
by end users is uncertain. This qualitative study aimed to explore end users’ views on the relevance of musculoskeletal
MoCs to their work and value of a standardised evaluation approach.
Methods: A cross-sectional qualitative study was undertaken. Subject matter experts (SMEs) with health, policy and
administration and consumer backgrounds were drawn from three Australian states. A semi-structured interview
schedule was developed and piloted to explore perceptions about musculoskeletal MoCs including: i) aspects
important to their work (or life, for consumers) ii) usefulness of standardised evaluation frameworks to judge ‘readiness’
and ‘success’ and iii) challenges associated with standardised evaluation. Verbatim transcripts were analysed by two
researchers using a grounded theory approach to derive key themes.
Results: Twenty-seven SMEs (n = 19; 70.4 % female) including five (18.5 %) consumers participated in the study. MoCs
were perceived as critical for influencing and initiating changes to best-practice healthcare planning and delivery and
providing practical guidance on how to implement and evaluate services. A ‘readiness’ evaluation framework assessing
whether critical components across the health system had been considered prior to implementation was strongly
supported, while ‘success’ was perceived as an already familiar evaluation concept. Perceived challenges associated
with standardised evaluation included identifying, defining and measuring key ‘readiness’ and ‘success’ indicators;
impacts of systems and context changes; cost; meaningful stakeholder consultation and developing a widely
applicable framework.
Conclusions: A standardised evaluation framework that includes a strong focus on ‘readiness’ is important to
ensure successful and sustainable implementation of musculoskeletal MoCs.
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Background
Australians enjoy one of the most accessible and high-
quality healthcare systems in the world when benchmarked
against other Organization for Economic Cooperation and
Development member nations [1, 2]. Like other developed
and, increasingly developing nations, health delivery sys-
tems and health policy makers are faced with the challenge
of adapting to the changing needs of its consumers [3].
Population health profiles are shifting healthcare priorities
from acute care needs and communicable diseases to
chronic, non-communicable conditions due to their in-
creasing prevalence [4], particularly musculoskeletal condi-
tions [5]. The system is also challenged with an active
reform agenda for primary and hospital-based care that in-
cludes changes to funding allocations, policy and govern-
ance and workforce roles [6].
In Australia, the morbidity and mortality burden im-
posed by chronic musculoskeletal conditions is second
only to cancer [7]. The prevalence and impact of muscu-
loskeletal conditions are projected to soar in Australia
and other developed nations [4, 8–11]. Furthermore,
across all areas of healthcare, including musculoskeletal
healthcare, there is a failure in the translation of evi-
dence on best practice from research into patient care
[12–15]. Addressing these issues requires research evi-
dence to articulate more efficiently with policy and prac-
tice to minimise the ‘evidence-practice’, ‘burden-policy’
and ‘burden-service’ gaps. Further changes required in-
clude health service care delivery; the manner in which
health professionals are trained and practice; and the
level of engagement by consumers in the management
of their health [7]. These shifts are required to optimise
health system responsiveness, sustainability and popula-
tion physical and mental well-being.
Historically, musculoskeletal conditions have not been
considered in a comprehensive manner in health policy
for chronic disease management or primary prevention
[16–19]. In recent years, this situation has been some-
what redressed, particularly in Australia, with the intro-
duction of state-wide and national Models of Care
(MoCs) for musculoskeletal health [7, 20] and other con-
ditions. MoCs provide evidence-informed blueprints for
the delivery of consumer-centred health services that are
tailored to meet local operational requirements. As such,
MoCs serve as a vehicle to drive evidence into policy
and practice at a jurisdictional level. Although the struc-
tural components of a MoC necessarily vary according
to its clinical or population focus, the core elements and
information provided are based around the framework:
right care, right time, right team, right place, and right
resources [20]. Development of MoCs will also vary de-
pending on the governance and health system processes
in given nations. In Australia, a Health Network model is
used to develop MoCs where cross-discipline stakeholders
(including consumers and carers) are connected to dis-
cuss, debate and recommend consumer-centred strategies
to address health issues [20]. A web of evidence is devel-
oping to substantiate the effectiveness of the implementa-
tion of specific musculoskeletal MoCs, as reported in our
recent international review [21], as well as uptake at a jur-
isdictional level [22–25].
There remains no standardised national approach to
the evaluation of musculoskeletal MoCs despite evidence
to support their effectiveness in improving consumer
outcomes and system efficiencies, and indications that
they continue to evolve and be promoted in Australia [7,
26] and internationally [27]. Furthermore, there is a
dearth of information in relation to evaluating MoCs
‘readiness’ for implementation as well as indicators of
successful implementation. Here, we broadly define
‘readiness’ as the content and development processes re-
quired to ensure implementation success and sustain-
ability, while ‘success’ is broadly defined as the outcomes
achieved after implementation. There is also limited data
on whether Australian end-users assign value to muscu-
loskeletal MoCs in their work or to a standardised evalu-
ation approach. The aim of this study was to explore
end users’ views on the relevance of musculoskeletal




Cross-sectional qualitative study, which is reported ac-
cording to the COREQ-32 checklist (refer to Additional
file 1) [28].
Sampling strategy
Subject matter experts (SMEs) across broad health, pol-
icy and consumer backgrounds were sampled for this
study, consistent with a recently published framework
[29]. SMEs were identified based on their established
role(s) in the development or implementation of MoCs.
Identification was made through established musculo-
skeletal networks, clinical leads of musculoskeletal ser-
vice and research programs, and policy makers who
have been involved in development or implementation
of musculoskeletal MoC, as we have reported previously
[20]. SMEs were sampled across three Australian states:
Western Australia (WA), New South Wales (NSW) and
Victoria (VIC). These states currently have the most ac-
tive policy, multidisciplinary engagement in musculo-
skeletal healthcare, and health services research activity
[7]. We also used snowballing methods to identify add-
itional SMEs, not necessarily known to the research
team, and who met the inclusion criteria. To ensure na-
tional representation and adequate heterogeneity of skill
sets, inclusion criteria and a minimum sample size for
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each discipline group, were defined a priori by the re-
search team (Table 1).
SMEs were invited to participate by personal email from
the research team. The email invitation provided a hyper-
link to a secure portal, powered by Qualtrics™ software
(Provo, Utah, USA). At this portal, SMEs were provided
with a background to the study and invited to consent to,
or decline, the invitation to participate. On accepting the
invitation to participate, SMEs were required to answer
screening questions to determine eligibility and to collect
demographic data. SMEs who declined the invitation were
invited to provide a reason for their decision and to nom-
inate other SMEs, facilitating snowballing recruitment.
Ethics, consent and permissions
The Human Research Ethics Committee at Curtin Uni-
versity approved this study (RDHS-08-14) and all partic-
ipants provided informed consent, including consent to
report de-identified participant-level data.
Development of interview schedule
Our multidisciplinary research team iteratively developed
a semi-structured interview schedule to explore SMEs
perceptions about:
i) aspects of musculoskeletal MoCs important to their
work (or life, for consumers); ii) the usefulness of stan-
dardised evaluation frameworks to judge ‘readiness’ of a
MoC prior to its implementation and successful imple-
mentation of a MoC iii) challenges associated with
evaluating MoCs pre and post-implementation.
A draft interview schedule was pilot tested with eight
SMEs who met the inclusion criteria (different from
those included in this study). Two from each stakeholder
group were interviewed using a cognitive interviewing
approach to determine whether the questions were gen-
erating the anticipated information [30]. A probing para-
digm was adopted where the interviewer (JEJ) asked
direct questions to assess comprehension of each ques-
tion, understanding of terminology used, and whether it
was easy or hard to answer. To allow for refinement of
Table 1 Inclusion criteria for subject matter experts. SMEs identified in each discipline were required to meet all the inclusion
criteria
SME discipline (a priori minimum sample size)
Health policy/strategy or
advocacy (n ≥5)
Clinical practice and/or clinical/health
services research (n≥6)






● At least one SME per state
of WA, VIC, NSW
● At least one SME reflecting
each of the sub-categories
below
● Experience at a seniora level
in musculoskeletal and/or chronic
disease (that implicitly includes
musculoskeletal health) health
policy or advocacy for at least
1 year
● Awareness of Australian
musculoskeletal MoCs as
defined by Briggs et al. [7]
● At least one SME per state of
WA, VIC, NSW
● At least one SME reflecting
each of the sub-categories
below
● Experience in delivery of
clinical care for people with
musculoskeletal conditions at
a senior practitioner levelb for
at least 5 years; or at least
5 years experience in
undertaking clinical and/or
health services research in
musculoskeletal health at a
senior levelb with evidence
of peer-reviewed publication(s)
in the area
● Awareness of Australian
musculoskeletal MoCs as
defined by Briggs et al. [7]
● At least one SME per state
of WA, VIC, NSW
● At least one SME reflecting
each of the sub-categories
below
● Experience in health service
or program delivery,
coordination, management





for at least 1 year at a
senior levelc
● Awareness of Australian
musculoskeletal MoCs as
defined by Briggs et al. [7]
● At least one SME per state
of WA, VIC, NSW
● Person lives with a chronic
musculoskeletal condition
(at least 5 years) or cares
for someone with a
chronic musculoskeletal
condition (at least 5 years)
● Awareness of Australian
musculoskeletal MoCs as
defined by Briggs et al. [7]
Sub-
categories
● State or federal government
health policy, strategy or MoC
development
● State or federal government
policy, strategy or MoC
evaluation
● State or federal government
health workforce policy or
strategy







● Pain or rehabilitation
medicine
● Community pharmacy
● Private health insurance
industry
● Health service management
or coordination at tertiary
setting
● Health service management
or coordination at primary
care setting
● At least one female
● At least one male
SME subject matter expert
MoC model of care
aat least senior officer or manager level of employment
bfellowship level for medical practitioners (e.g. FRACP, FRACGP); senior clinician level for other disciplines; associate professor level for researchers
cat least at the manager or head of department level
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questions, two rounds of four interviews were conducted
1 week apart. Based on feedback from the first round of
piloting, a separate consumer interview schedule was de-
veloped. The consumer schedule was shorter than the ori-
ginal and re-worded to explore the same concepts using
consumer-centred language. The second round of inter-
views did not provide any further insights in relation to
comprehension of questions, and therefore no further
pilot interviews were undertaken.
Data collection
Data were collected in April 2015 by four interviewers
experienced in qualitative methods (AMB, HS, MJ, RS).
The interviewers had a broad range of career skills in-
cluding clinical practice in musculoskeletal healthcare
(AMB, HS, MJ), clinical practice across chronic diseases
(RS), health service management experience (MJ), edu-
cation (HS), health services research (AMB, HS, RS),
health policy (AMB, RS) and MoC development, imple-
mentation and evaluation (AMB, HS, MJ, RS). Given
cross-sector and cross-discipline experience of the inter-
viewers and the sampling strategy used, some of the
SMEs were known to the interviewers. In this context,
the possible threat of responder bias was unavoidable
since we identified a priori that a minimum level of con-
textual experience among SMEs was needed in order to
provide meaningful data. To minimise any risk of
dependent relationships, interviewers only interviewed
SMEs where no direct reporting, working, personal, or
financial relationship existed. To ensure consistency be-
tween interviewers, a senior qualitative researcher (JEJ)
provided training to the interviewer team. Specifically
this involved tailoring interviews to the knowledge and
experience of interviewees, use of specified probing
questions, and paraphrasing answers to confirm under-
standing [31]. Interviews were conducted by telephone
and audio-recorded.
Data analysis
Interviews were transcribed verbatim and analysed in-
dependently by two researchers: one a qualitative
methods expert (JEJ) and the other a content expert
(AMB). An inductive analysis based on grounded the-
ory was used [32]. All transcripts were initially
reviewed and codes derived from the data. Through an
iterative process of reviewing transcripts and generat-
ing codes, the codes were further refined, grouped into
concepts where similarities amongst codes existed, and
key themes developed. Where discordance between an-
alysts was identified, and where appropriate to gain
consensus, these were discussed and transcripts re-
reviewed. Descriptive statistics were used to character-
ise the SMEs.
Results
Twenty-seven SMEs (n = 19; 70.4 % female) participated
in the study across three states (WA: 12; NSW: 10; VIC:
5). Interview duration ranged from 18 to 52 min. Five
(18.5 %) of the 27 SMEs were consumers. Three (11.1 %)
SMEs reported some awareness of the Australian mus-
culoskeletal MoCs, 10 (37.0 %) reported having reviewed
at least one MoC, and 14 (51.9 %) reported having been
involved in the development and/or implementation of
at least one MoC. A summary of SME demographic
characteristics is provided in Table 2.
Qualitative results are presented under the following
headings:
1. Aspects of musculoskeletal MoCs that are important
to stakeholders’ work.
2. Perceptions of standardised evaluation frameworks
to judge ‘readiness’ and ‘success’ of musculoskeletal
MoCs.
3. Challenges associated with evaluating
musculoskeletal MoCs.
Where the term MoC is referred to, this relates to
musculoskeletal MoCs.
Aspects of musculoskeletal MoCs that are important to
stakeholders’ work
MoCs were perceived as critical for providing a plat-
form to influence and initiate changes to healthcare
delivery, so as to align it with best-practice (see MoC
as platform for change section), as well as providing
practical guidance on how to implement and evaluate
services (see MoC providing practical guidance to imple-
ment and evaluate services section).
“…we should all be evidence-based practitioners and
we should be all trying to implement evidence into what
we do, and so I see models of care and evaluation of
Models of Care as an integral component of that” (SME
8)
MoC as platform for change
In considering MoCs as providing a platform for sector
change, four critical information components were iden-
tified to imbue credibility in a MoC and increase the
likelihood of uptake by stakeholders:
 the development and consultation processes
 a compelling case for change
 a clear outline of objectives, core elements and
anticipated outcomes, along with performance
indicators to evaluate outcomes
 a description of how services and resources would
be delivered.
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Inclusiveness in development of a MoC The strongest
theme to emerge was the need to demonstrate that a
broad range of stakeholders had been consulted from in-
ception of the MoC. This included representatives across
the care continuum (i.e. primary through to tertiary sector)
and different sectors (i.e. private, public, non-government,
consumers, community).
“That the end product can demonstrate that its had
the input from the right professions… it’s very much
having a representative group…you know,
multi-disciplinary, as well as having the people with
influence, the colleges, the association, that kind of
stuff. And involving them from the beginning. So, not
just bringing them to review something at the end. It’s
actually they’re involved in drafting and developing.”
(SME 7)
Further, without endorsement from influential change
champions and organisations, SMEs warned that MoCs
can be perceived as incomprehensive, which would nega-
tively affect engagement, or at worst, result in stakeholders
being unaware of the MoC’s existence or ambivalent to it.
Table 2 Demographic characteristics of the sample
SME discipline category Current profession N (%)a Mean (SD) years in current
professional role
[range]
Health policy/strategy or advocacy Health policy and/or program development
for chronic disease
14 (51.9) 12.6 (6.5)
[4–30]
Public health system funding 4 (14.8) 6.3 (2.9)
[4–10]
Advocacy and/or consumer representation for
musculoskeletal health
4 (14.8) 14 (12.4)
[4–32]
Health workforce policy/strategy 8 (29.6) 12.1 (6.6)
[3–25]
Clinical practice and/or clinical/health
services research
Clinical practice in musculoskeletal healthcare
(currently active)
8 (29.6) 26.3 (4.7)
[20–32]
General practice 2 (7.4)
Endocrinology 1 (3.7)
Rheumatology 2 (7.4)
Pain/rehabilitation medicine 1 (3.7)
Community pharmacy 1 (3.7)
Physiotherapy 1 (3.7)
Clinical practice in musculoskeletal healthcare
(currently inactive)
General practice 1 (3.7)
Physiotherapy 3 (11.1)
Clinical and/or health services research in
musculoskeletal healthcare
4 (14.8) 21 (7.2)
[15–29]
Tertiary education of healthcare professionals 7 (25.9) 15.7 (8.3)
[7–30]
Health service or program delivery Health service delivery, coordination or
management related to chronic diseases
10 (37.0) 14 (8.0)
[5–30]
Private health insurance 2 (7.4) 1.5 (0.7)
[1-2]
Consumer Consumer 5 (18.5) 31.8 (14.6)
[15–50]
Other Other (health economics; primary care system
change and capacity building; development
and evaluation of healthcare models
3 (11.1) 20.0 (5.0)
[15–25]
acategories are not mutually exclusive, therefore the sum does not equal 27
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“Well I think the bad thing is, as a community
pharmacist, a Model of Care is really not important to
my work at all - it should be, but it’s not. And I think
that’s because as a community pharmacist I had
absolutely no awareness of [its] existence…” (SME 15)
Establishment of a case for change A compelling case
for change was also considered vital for uptake. This in-
cluded a justification being based not only on best evi-
dence, but also local data (jurisdictional/national),
previous experiences and learnings and local expert
opinion. Detailing the benefits of the MoC, how it would
address ‘known’ local problems within the sector, and
how proposed services would be integrated into existing
service delivery models, were also perceived as essential.
“I would be interested in…the argument for the
evidence in which the Models of Care are based and
how that fits in the service delivery models both in
terms of an economic perspective and also an
integrated sort of model.” (SME 2)
“It’s got to be safe, so the safety elements have to be
considered strongly. It must either improve or at least
maintain the quality of care that’s already likely one
would hope improve, but certainly not in any way
diminish. It has to ensure that the effectiveness of
care is going to be improved or again at least
maintained…It should improve the patient journey
and the patient experience. It should increase the
efficiency from a service or system perspective.” (SME 5)
Providing a clear outline Across disciplines, strong em-
phasis was placed on the MoC clearly defining its scope,
objectives and outcomes. The language in the document
needed to be meaningful to different stakeholders and to
delineate between the core and non-essential compo-
nents of the model. SMEs from primary care, in particu-
lar, stressed the need for simple, translatable strategies
to assist implementation.
“One of the most important things is having a
document which is actually going to be understandable
to a person outside of that special [musculoskeletal]
area…that specific managers understand it as well as
clinicians [and] consumers.” (SME 13)
“And they’re [General Practitioners] not interested in
pages of documentation, they’re not interested in the
eighty page Model of Care document; they’re
interested in two pages… Give it to me simply; have
you got an assessment for me with my package that I
can use, and how do I do it, and who do I refer to?
Keep it really simple with a link to the more detailed
document.” (SME 22)
Describing how services could be delivered Detailing
how musculoskeletal services would be delivered was of
high importance to SMEs involved in providing health
services and consumers. This included access and ser-
vice components, as well as education strategies and
support mechanisms for both health professionals and
consumers.
“… as a clinician I think the most important things
are that it [MoC] sets down…the way in which care
will be delivered for people with musculoskeletal
conditions…so that there’s hopefully a clear pathway
with services available and accessible that need to be
delivered in line with the model of care.” (SME 14)
Consumers specifically advocated that MoCs were im-
portant in facilitating the provision of accessible multi-
disciplinary services that are ideally located in the
community. Examples included outreach and telehealth
services. Consumers also identified the need for MoCs
to include an emphasis on early identification and man-
agement, psychosocial health, and transition services for
adolescents.
“I think probably the key point is access…consumers
need to be able to access these opportunities easily
with the minimal cost and reduced waiting times, and
to be able to have a service that gives them as much
multidisciplinary care as possible.” (SME 24)
MoC providing practical guidance to implement and
evaluate services
The second key aspect of MoCs that was important to
SMEs’ work was providing practical and detailed consider-
ations for implementation and evaluation of changes to ser-
vice delivery. A fundamental component was the
demonstration of pilot testing across diverse sites to pro-
vide insight into outcomes and adaptability.
“I’d like to see whether a pilot study has been run in a
small number of sites of different, maybe, locations and
environments to make sure that the Model of Care is
both effective, but is also generalizable.” (SME 12)
“…particularly when you see a preliminary
evaluation– if there’s pilot studies done and we’ve,
you know, had that advantage in New South Wales
obviously to do some pilot studies and then present
the results from the pilot studies, then I think that’s
really important because they [stakeholders] say “Oh,
I want that too…””(SME 20)
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SMEs cited several practical components that were im-
portant to be included in a MoC to assist with implementa-
tion. This included identifying system requirements for
implementation; detailing how a new MoC would replace
an old or existing MoC; prioritising components for imple-
mentation and providing implementation plans or business
cases. Similarly, guidance was also sought in relation to
evaluation processes and identification of data sources to
assist with evaluation.
“I think in advance it’s also helpful to make sure that
the evaluation that you’d like to do at the end is
thought about…so what on a day do you want to
capture and systems that are required for that, and
the person burden, but also resource burden in
developing and implementing that…” (SME 10)
“…there’s a step between the Models of Care and then
what it is that you plan to implement. The work we
did…was trying to look at how you turn the Model of
Care into discreet programs. I think there needs to be
a lot more work of that nature. The real lesson…is
that those processes then need rigorous project
methodology and do need very structured
implementation targets.” (SME 19)
Perceptions of standardised evaluation frameworks to
judge ‘readiness’ and ‘success’ of musculoskeletal MoCs
There was unequivocal endorsement for a framework that
assessed whether critical components across the broader
health system had been considered or were ready prior to
implementation of an MoC; i.e. a ‘readiness’ framework
(Evaluating the readiness of a MoC section). While evaluat-
ing the ‘success’ of an implemented MoC was considered
important (Evaluating success of an implemented MoC sec-
tion), this was perceived as an already familiar concept with
a reasonably well established and understood approach,
compared to an appraisal of ‘readiness’. The need for a
structured approach to judging readiness resonated strongly
with SMEs, based on their experiences with premature and
unsuccessful implementation.
“I think an “evaluability assessment” or “readiness
assessment”, whatever it’s called, is really, really
important… [there have been] so many evaluations
where you’ve gone in to do it and not only has it not
been ready to implement, the enablers aren’t in place to
support a new Model of Care, staff perceptions are
quite obtuse, but there might not even be a baseline”
(SME 4)
Evaluating the readiness of a MoC
A readiness evaluation framework was perceived as valu-
able in providing assurance to stakeholders that essential
elements required for implementation are present in the
target environment and that known barriers have been
removed or worked through.
“…because it is difficult to know [when a MoC is
ready] because so many parts of the system and such
a wide variety of things need to align that it’s difficult
to know when all of that stuff is aligning up…so some
sort of framework or structured way or a model that
could take you through…and give you the confidence
that it’s now ready would be very valuable.” (SME 1)
The concept of readiness included assessing stake-
holders’ willingness to change and whether the MoC
was usable in the current environment. This was per-
ceived as critical in building receptiveness towards the
MoC.
“… it comes down to the whole principles of change
management and whether you’ve got a receptive
audience. Do you have fertile ground in which to
plant this thing?” (SME 19)
“So I think it’s really important to make sure you’ve
got everything, all the ingredients right, the context is
right, that the people involved are ready and engaged
with it, ready to deliver it and embrace it before you
actually implement it and evaluate it.” (SME 8)
SMEs were also wary of any readiness evaluation
framework being overly simplistic, and thus not capable
of capturing the complexities of a dynamic healthcare
environment or adapting across different environments.
Similarly, SMEs cautioned that an evaluation framework
should not be too prescriptive so that it became an obs-
tacle to conducting meaningful evaluations.
“…in some ways I think there can be a tendency to
boil everything down to a checklist, and that concerns
me as well.” (SME 4)
“…it’s got to be seen as a value add exercise and not
something that’s just kind of ticking a box to do a
function that you know may or may not be
useful.”(SME 14)
Evaluating success of an implemented MoC
SMEs strongly identified the need to distinguish between
an evaluation of the implementation of a MoC (process
evaluation) and an evaluation of the outcomes associated
with the MoC itself (impact evaluation).
“…if you want to make statements or judgments
about the effectiveness of a Model of Care, which
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presumably at some point you would want to because
the whole – one of the purposes behind a Model
of Care is to improve…and you can’t make judgments
about effectiveness if you don’t know whether it’s
been implemented appropriately in the first
instance…” (SME 8)
“I guess we need to measure what we do to know
whether we’re making a difference…I mean, we’re in a
place of increasing need and demand, and we have
finite resources, so…measuring what we do is
important to make sure that it’s delivering value, so
value in terms of quality and cost”. (SME 7)
Using a framework to inform a structured approach to
exploring and documenting lessons learnt from imple-
mentation efforts was also deemed valuable. This pro-
vided opportunities for continued engagement with
stakeholders and ongoing quality improvement for im-
plementation efforts.
“I think measuring people’s commitment to the
implementation and to the Model of Care is very
telling so that’s really very important…how they’ve
been engaged and enabled to change whatever it is
that they have needed to change. That can be rich I
think in terms of what you might do the next time,
both good and bad…so what we might not do, but
also but what you might want to replicate.” (SME 2)
“…evaluation is obviously also critically important for
consumer satisfaction and potential need for
modifying the Model of Care, assessing the
consistency of uptake and obviously the acceptability
to the stakeholders” (SME 9)
A standardised framework that facilitated evaluation of
MoCs across sites, and even jurisdictions, was perceived
as highly useful for the sector.
“…if there were a particular framework that could be
used, then there is some measure of comparison
rather than, well we evaluated this [MoC]
implementation by this process but another
evaluation process was used for [another] Model of
Care…” (SME 3)
Challenges associated with evaluating musculoskeletal
MoCs
Whilst SMEs supported standardised evaluation frame-
works to judge the readiness and success of MoCs, they
were cognisant of the many challenges associated with
this. Of these, the strongest themes to emerge were: (i)
identifying, defining and measuring key indicators that
adequately reflect ‘readiness’ and ‘success’ of a MoC
(Identifying, defining and measuring indicators of readi-
ness and success section) and (ii) recognising the poten-
tial impacts of systems or context changes within a
dynamic healthcare environment on prospective evalua-
tions (Impacts of systems or context changes on pro-
spective evaluations section). Other challenges included
system constraints, cost of evaluation, meaningful con-
sultation with stakeholders and developing a framework
that is applicable across diverse jurisdictions and health-
care settings (Other challenges section).
Identifying, defining and measuring indicators of readiness
and success
While SMEs strongly indicated the need for an evalu-
ation framework to be flexible and take into account dif-
ferent contexts and changing environments, they also
identified perceived challenges. These included develop-
ing specific indicators that appropriately reflected readi-
ness and success from MoCs and achieving consensus
amongst stakeholders as to how these should be mea-
sured and defined.
“…Models of Care are pretty high level documents
and as such they often lack that specificity or that
operational level of detail and specificity of activities
that allow for betterment, so it can be very difficult to
know where to target your measures and determine
what to measure. And then, yeah, there’s often a lack
of agreement I think about how to measure, is
something ready to be measured…” (SME 1)
SMEs identified that musculoskeletal conditions are
highly diverse in their presentations and are very com-
monly co-morbid to other chronic health conditions.
This complexity creates considerable heterogeneity in
cohorts being evaluated and is a challenge to evaluation
initiatives.
“ one [challenge] that I’ve also eluded to is the
comorbidity - the fact that our patients are
wonderfully diverse and that’s often our biggest
dilemma is trying to decide whether somebody who’s
got so many comorbidities is still worthwhile trying to
include in it [MoC] or whether you know they are so
different in all other respects and there only going to
be a confounder.” [SME 11]
Impacts of systems or context changes on prospective
evaluations
SMEs noted that the speed at which healthcare environ-
ments change could make evaluation difficult or render
it out of date quickly. Risks were also perceived in attrib-
uting causation of observed outcomes to a MoC (either
Briggs et al. BMC Health Services Research  (2015) 15:509 Page 8 of 13
positively or negatively) given multiple influential factors
present in any healthcare setting.
“… but the Model of Care is probably only one of the
things that accounts for improved or changed
outcomes in the patient population. Because almost
invariably there are other things happening at the
same time, some of them planned and some of them
unplanned. So the evaluation framework around the
Model of Care is very important but I think we have
to also be a bit pragmatic and remind ourselves that
sometimes when there is a change in outcomes,
whether it’s good or bad, there is probably a number
of factors impacting upon it and that’s always the
dilemma…” (SME 11)
Other challenges
Of the several other challenges cited by SMEs relating to
the development of an evaluation framework (Table 3),
creating a framework that is applicable to different
MoCs across jurisdictions was the most complex. This
related not only to the range of different condition-
specific musculoskeletal MoCs available and those likely
to be developed, but also geographic variability in imple-
mentation sites such as urban and rural settings, and
consequent variability in the availability of resources and
workforce, modes of care delivery, and funding models.
“…but national consistency and quality in a country
like Australia, not just the [geographical] vastness, but




Australian stakeholders in this study perceived MoCs to
be critical enablers for system and service delivery re-
form and a blueprint for implementation and evaluation
of new services. Our data are consistent with previously
published reports, where MoCs have been identified as a
Table 3 Other challenges associated with evaluating Models of Care
Key theme Summary description Illustrative quote
System constraints Implementation of a MoC into an existing system may be
unfeasible due to constraints within the current system.
For example, some of the aspects of the MoC might
need system enablers in place (e.g. new IT infrastructure),
so implementation and subsequent evaluation cannot
proceed successfully until system changes are completed.
Additionally system design constraints, such as the split
health funding models between the Australian
Commonwealth and State/Territory governments, also
presents as a significant barrier to evaluation across
settings.
“So I think they’re all external constraints and it’s around
the purchasing plan. So this is the amount of activity you
will do and you know, this is the dollars that are attached
to that because it’s worth you know, X number of dollars
to – episode of care or service event and then it depends
very much on the types of service models that the area
health services or the local health network are wanting to
implement. So depending on what the service models
are, what the funding sources are, what the purchasing
plans say, it’s really hard to do a pre and a post
evaluation…”(SME 18)
Cost of evaluation It was emphasised that evaluations can be resource
intensive, depending on the study design, governance
and data collection arrangements. SMEs indicated that
external funding and partnership with Universities are
ideally needed to assist with the collection of data
(particularly an issue in the primary healthcare sector).
“One of the biggest issues we have in evaluating in
general practice is that they don’t get paid for this sort of
work…I actually get quite frustrated that it always ends
up coming down to a dollar figure, but general practice
isn’t paid to stop it’s work and to write an evaluation or
to do a survey…one of the things that worked very
well…they incentivised general practice to participate pre
and post. It’s not a lot but to ensure that their nurse will
be able to collect the information…” (SME 22)
Ensuring adequate
involvement of stakeholders
within the evaluation process
SMEs emphasised the need to ensure adequate
involvement of stakeholders within evaluation processes
in order to obtain a comprehensive understanding of
issues relating to implementation and outcomes.
Challenges in engaging stakeholders in evaluations
included:
"I think quite often people jump to a solution and think
they know the answer…we actually firstly need to have
all the right people in the room, and when I say the right
people, I don’t just mean the best clinicians, I also mean
management of front line and I mean people who have
a state wide role in funding and planning and some
consumers.” (SME 16)
● Ensuring all relevant stakeholders are involved, given
diversity and complexity of healthcare settings relevant
to musculoskeletal health, particularly in the private
community setting.
● Getting stakeholders to understand the need to build
evaluation into the entire process of a MoC; i.e. from
inception to implementation.
● Achieving a cohesive understanding of terminology
relating to MoCs across diverse stakeholders in
different sectors of the care continuum.
SME subject matter expert
MoC model of care
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mechanism to guide service planning and delivery for
chronic health conditions [33–35], particularly musculo-
skeletal conditions [7, 21, 27, 36]. Importantly, we identi-
fied that MoCs hold different values to different
stakeholders and that these value propositions could be
enhanced and sustained by recognition of this diversity in
the development of MoCs. Further, despite a range of
challenges identified to achieving meaningful and valid
evaluation outcomes, stakeholders agreed that an evalu-
ation framework for musculoskeletal MoCs that included
a strong focus on ‘readiness’ was important to ensure suc-
cessful and sustainable implementation of musculoskeletal
MoCs. While our focus was on musculoskeletal MoCs
specifically, we suggest that our findings have relevance to
MoCs for chronic diseases more broadly.
Relevance of MoCs to stakeholders’ work
Stakeholders stressed the need for MoCs to be user-
relevant and system-relevant, and that broad sector buy-
in of the MoC was fundamental to achieving any mean-
ingful level of sustainable implementation. Health and
policy professionals cited the need for MoCs to adopt
robust and comprehensive consultation methods and to
clearly articulate a case for change and to identify per-
formance indicators. In contrast, consumers identified
the need for the MoC to address accessibility of services,
particularly multidisciplinary care; consider support
structures for families and adolescents; and directly ad-
dress psychosocial health. These consumer-centred
views on service planning and delivery align with other
recent consumer reports [37–39] and highlight the im-
portance of engaging these perspectives alongside other
stakeholders. These different foci of relevance are reflect-
ive of the distinct ways in which these two stakeholder
groups interact with the health system – one being a ser-
vice administrator and delivery agent where processes,
governance and adoption are important; and the other a
consumer where point-of-care, access, scope and equity
matter. Notably, a recent systematic review examining the
effectiveness of chronic care models for health outcomes
and health practices (for diabetes, cardiovascular disease,
depression and chronic respiratory diseases), identified
that of the 77 papers included in the review, only two in-
cluded family support as part of the model, perhaps indi-
cative of inadequate consumer input into the model
design [33]. Further, another recent systematic review re-
ported greater operational success in chronic care models
when consumer perspectives were included [40].
Meaningful consultation, inclusive of a broad range of
stakeholders, was considered an overall imperative in
the development and planning implementation of a
MoC. Inadequate or tokenistic engagement and consult-
ation is a recognised barrier to uptake of programs, pol-
icies and models [41]. Australian MoCs, for example are
generally developed through a network-based model of
engagement, consultation and iterative implementation
[20]. Such network-developed models are reported to be
acceptable to stakeholders [26, 42], associated with im-
proved outcomes for consumers [43], and identified as a
facilitator to implementation of chronic care models
[40]. Implicit within consultation, was the need for iden-
tification and engagement of clinical and administrative
‘change champions’ to support the development and im-
plementation of a MoC; an established strategy for
achieving knowledge translation into policy and practice
[44–46]. Organisational champions have been similarly
identified as important agents for facilitating organisa-
tional adoption of new programs or MoCs [33, 40, 47].
A compelling case for change was also identified as an
important enabler for sector engagement. Bleser and col-
leagues reported that providing evidence-informed argu-
ments is an effective strategy for achieving intellectual
buy-in amongst stakeholders [47]. SMEs identified this
could be facilitated by using local data, such as local
costing [48], activity [49] or access data [50] that was
meaningful to health administrators. While burden of
disease and national or international data are compel-
ling, where feasible, these should be supplemented by
comparable data at a local level. This enabler has also
been reported in other recent studies [47].
All stakeholders, perceived value in MoCs as a blueprint
for guiding implementation efforts and specifically provid-
ing detail on how services could be delivered to a commu-
nity. The use of locally derived pilot data to demonstrate
proof of concept for a particular MoC was considered an
important enabler in this regard. For example, the ex-
tended rollout of a system inversion MoC for pain man-
agement services in Western Australia has been facilitated
by initial pilot work in program delivery [51] and aligned
health workforce and consumer education [52–54]. In this
context, a MoC could be considered as a knowledge trans-
lation intervention. Support for pragmatic, health services
and implementation research is therefore an important
consideration for those tasked with the development and
implementation of MoCs.
A further identified enabler was the provision of a de-
tailed implementation plan, or guidance on the develop-
ment of a business plan. This enabler resonates, for
example, with international initiatives to develop fracture
liaison services for osteoporotic fractures [55]. A concerted
international effort has been made to evaluate MoCs for
re-fracture prevention and to provide guidance on specific
implementation strategies and quality standards [56].
Development of an evaluation framework and associated
challenges
SMEs identified evaluation of MoCs as a fundamental
principle, and ideally a routine practice after
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implementation to confirm improvements in service
quality, efficiency and consumers’ access and satisfac-
tion – arguably, elements defining ‘success’. However,
the concept of an evaluation of ‘readiness’ for implementa-
tion was less familiar, yet very strongly supported, particu-
larly in the context of assessing organisational readiness
for change as one important component of an overall
judgement of readiness. Notably, this was also the most
significant challenge identified by the SMEs in this study.
Although the state of New South Wales uses formative
evaluation to examine readiness and applicability, and
summative or impact evaluation to determine success, this
approach is not completely standardized or nationally
adopted [57].
In the business sector, organisational readiness for
change is routine and well described, such as Kotter’s 8
Step model [58]. However, these concepts, skillsets and
evaluation capabilities are arguably less well developed
in healthcare environments, and is perhaps one factor
underpinning unsuccessful implementation of MoCs [25,
59]. In one of the largest systematic reviews conducted
to date on the effectiveness of chronic care models, Davy
and colleagues [33] reported that no differences could
be identified in health and practice outcomes between
variant models. It was, therefore, impossible to identify
which aspects of the chronic care models led to im-
provements in health outcomes and practices. They con-
cluded that factors other than the implementation of the
model per se, particularly organisational, personal and
communication-related, have an important influence on
outcomes. A recent review of organisational readiness
for change in healthcare identified that psychological
and structural domains were the most important do-
mains to consider [60]. However, currently available
tools to assess these domains lacked reliability and con-
tent, construct and predictive validity [60]. That review,
and others [61–63], support the concept that a frame-
work to evaluate readiness is needed, particularly as it
relates to implementation of chronic disease MoCs [59],
and should consider psychological and structural factors
[62]. It is not surprising then, that several protocol pa-
pers to develop organisational readiness for change tools
have been published recently [59, 64, 65] and import-
antly, reflect just one component of an overall judge-
ment of MoC readiness.
Strengths and limitations
This is the first study to qualitatively explore Australian
stakeholders’ views on contemporary MoCs for muscu-
loskeletal health. Strengths include purposeful sampling
across multiple stakeholder groups, including consumers
[41]; iterative development of an interview schedule in-
formed by pilot testing; and data analysis by a content,
as well as methods, expert. While there were clear and
recurrent themes identified across stakeholders suggest-
ive of data redundancy, a limitation, in the context of a
grounded theory analytical approach, is that we did not
validate our conceptualisation of MoC relevance and
evaluation with a wider range of stakeholders [66]. There
is also a possibility of selection bias in terms of individuals
who participated in this research. For example, these indi-
viduals may have been more interested in the topic, and
therefore more willing to participate. Further, our inclusion
criteria and sampling strategy was established a priori to
ensure that SMEs had a minimum level of senior, profes-
sional experience relevant to our research question and a
minimum level of understanding or experience with Aus-
tralian musculoskeletal MoCs in order to collect meaning-
ful and appropriately-contextualised data. Our data,
therefore, reflect the views of stakeholders with experience
and a contextual background in the area and not of stake-
holders who are naïve to Australian musculoskeletal MoCs.
Although this design choice limits generalizability of the
findings to the categories of stakeholders sampled, we do
not consider this a limitation, but rather a focused design
strategy to address the research question, which is an ap-
proach congruent with qualitative research principles, par-
ticularly purposive sampling [67]. Further, our purposive
sampling approach ensured a spread in experiences and fa-
miliarity with the MoCs (Table 1). A limitation in our sam-
pling approach was the absence of representation from the
orthopaedic surgery discipline. In the current study, we
intentionally did not aim to define the components of, or
criteria for, a ‘readiness’ and ‘success’ evaluation framework,
as this is the focus of ongoing research by our group.
Conclusions
MoCs appear critical for influencing and initiating changes
to best-practice healthcare delivery, and for practical guid-
ance on how to implement and evaluate services. An
evaluation framework for musculoskeletal MoCs that is
particularly focused on capturing ‘readiness’ is important
to ensure successful and sustainable implementation ef-
forts. Balancing sufficient detail against an overly simplistic
evaluation framework and identifying organisational readi-
ness for change are key challenges in this regard.
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